TY - JOUR
T1 - Genital abnormalities in Pallister-Hall syndrome
T2 - Report of two patients and review of the literature
AU - Narumi, Yoko
AU - Kosho, Tomoki
AU - Tsuruta, Goro
AU - Shiohara, Masaaki
AU - Shimazaki, Ei
AU - Mori, Tetsuo
AU - Shimizu, Ayako
AU - Igawa, Yasuhiko
AU - Nishizawa, Shuji
AU - Takagi, Kimiyo
AU - Kawamura, Rie
AU - Wakui, Keiko
AU - Fukushima, Yoshimitsu
PY - 2010/12
Y1 - 2010/12
N2 - We describe two patients with Pallister-Hall syndrome (PHS) with genital abnormalities: a female with hydrometrocolpos secondary to vaginal atresia and a male with micropenis, hypoplastic scrotum, and bilateral cryptorchidism. Nonsense mutations in GLI3 were identified in both patients. Clinical and molecular findings of 12 previously reported patients who had GLI3 mutations and genital abnormalities were reviewed. Genital features in the male patients included hypospadias, micropenis, and bifid or hypoplastic scrotum, whereas all the females had hydrometrocolpos and/or vaginal atresia. No hotspot for GLI3 mutations has been found. The urogenital and anorectal abnormalities associated with PHS might be related to dysregulation of SHH signaling caused by GLI3 mutations rather than hormonal aberrations. We recommend that clinical investigations of genital abnormalities are considered in patients with PHS, even those without hypopituitarism.
AB - We describe two patients with Pallister-Hall syndrome (PHS) with genital abnormalities: a female with hydrometrocolpos secondary to vaginal atresia and a male with micropenis, hypoplastic scrotum, and bilateral cryptorchidism. Nonsense mutations in GLI3 were identified in both patients. Clinical and molecular findings of 12 previously reported patients who had GLI3 mutations and genital abnormalities were reviewed. Genital features in the male patients included hypospadias, micropenis, and bifid or hypoplastic scrotum, whereas all the females had hydrometrocolpos and/or vaginal atresia. No hotspot for GLI3 mutations has been found. The urogenital and anorectal abnormalities associated with PHS might be related to dysregulation of SHH signaling caused by GLI3 mutations rather than hormonal aberrations. We recommend that clinical investigations of genital abnormalities are considered in patients with PHS, even those without hypopituitarism.
UR - http://www.scopus.com/inward/record.url?scp=78649645166&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649645166&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.33720
DO - 10.1002/ajmg.a.33720
M3 - Article
C2 - 21108399
AN - SCOPUS:78649645166
SN - 1552-4825
VL - 152 A
SP - 3143
EP - 3147
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 12
ER -